DE69119900D1 - Verwendung von Prostaglandin F3alpha als okulares Hypotensivum - Google Patents

Verwendung von Prostaglandin F3alpha als okulares Hypotensivum

Info

Publication number
DE69119900D1
DE69119900D1 DE69119900T DE69119900T DE69119900D1 DE 69119900 D1 DE69119900 D1 DE 69119900D1 DE 69119900 T DE69119900 T DE 69119900T DE 69119900 T DE69119900 T DE 69119900T DE 69119900 D1 DE69119900 D1 DE 69119900D1
Authority
DE
Germany
Prior art keywords
prostaglandin
f3alpha
ocular hypotensive
reducing
intraocular pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69119900T
Other languages
English (en)
Other versions
DE69119900T2 (de
Inventor
David Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DE69119900D1 publication Critical patent/DE69119900D1/de
Publication of DE69119900T2 publication Critical patent/DE69119900T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Exposure Control For Cameras (AREA)
DE69119900T 1990-03-12 1991-02-12 Verwendung von Prostaglandin F3alpha als okulares Hypotensivum Expired - Fee Related DE69119900T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/491,546 US5011856A (en) 1990-03-12 1990-03-12 Use of prostaglandin F3 α as an ocular hypotensive agent
PCT/US1991/000988 WO1991013620A1 (en) 1990-03-12 1991-02-12 USE OF PROSTAGLANDIN F3α AS AN OCULAR HYPOTENSIVE AGENT

Publications (2)

Publication Number Publication Date
DE69119900D1 true DE69119900D1 (de) 1996-07-04
DE69119900T2 DE69119900T2 (de) 1997-02-06

Family

ID=23952683

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69119900T Expired - Fee Related DE69119900T2 (de) 1990-03-12 1991-02-12 Verwendung von Prostaglandin F3alpha als okulares Hypotensivum

Country Status (11)

Country Link
US (1) US5011856A (de)
EP (1) EP0527748B1 (de)
JP (1) JPH05504962A (de)
AT (1) ATE138574T1 (de)
CA (1) CA2075951A1 (de)
DE (1) DE69119900T2 (de)
ES (1) ES2088489T3 (de)
FI (1) FI924088A0 (de)
HU (1) HUT61470A (de)
IE (1) IE910794A1 (de)
WO (1) WO1991013620A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270049A (en) * 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055593A (en) * 1971-02-19 1977-10-25 Alza Corporation Alkyl diethers of prostaglandins
US3940438A (en) * 1971-05-24 1976-02-24 Alza Corporation Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
US3882245A (en) * 1972-11-01 1975-05-06 Upjohn Co Use of prostaglandins in combating shock
US3941886A (en) * 1973-09-21 1976-03-02 Alza Corporation Pharmaceutical compositions containing crystalline racemic 9α, 11α, 15(S)-trihydroxy-5-cis, 13-trans-prostadienoic acid
US4049678A (en) * 1976-03-29 1977-09-20 The Upjohn Company 9-Deoxy-PGD-type, 1,15-lactones
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4033989A (en) * 1975-09-17 1977-07-05 The Upjohn Company 9-Deoxy-PGF2 Analogs
US4201873A (en) * 1975-09-17 1980-05-06 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD2 analogs
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US4149007A (en) * 1977-06-23 1979-04-10 Miles Laboratories, Inc. C14 Phenyl-substituted derivatives of prostaglandin analogues
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
EP0286903B2 (de) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes
SE8703854D0 (sv) * 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension
DE69129238T2 (de) * 1990-12-10 1998-12-03 Allergan Inc Okulare hypotensive homo-prostaglandinderivate

Also Published As

Publication number Publication date
JPH05504962A (ja) 1993-07-29
HUT61470A (en) 1993-01-28
EP0527748A1 (de) 1993-02-24
US5011856A (en) 1991-04-30
DE69119900T2 (de) 1997-02-06
EP0527748B1 (de) 1996-05-29
ATE138574T1 (de) 1996-06-15
ES2088489T3 (es) 1996-08-16
WO1991013620A1 (en) 1991-09-19
EP0527748A4 (en) 1993-03-10
FI924088A (fi) 1992-09-11
FI924088A0 (fi) 1992-09-11
CA2075951A1 (en) 1991-09-13
IE910794A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
YU47204B (sh) Derivati didehidro-vitamina d3
DK486282A (da) Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider
AU7610696A (en) Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
DK0646008T3 (da) Minimering af gennemblødning i forbindelse med progestin
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
ES2046500T3 (es) Derivado de la histamina, su preparacion y su aplicacion en terapeutica.
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
PT684816E (pt) Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
DE69119900D1 (de) Verwendung von Prostaglandin F3alpha als okulares Hypotensivum
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ES2175437T3 (es) Composicion de enalapril y losartan.
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE69116224T2 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
ES2162078T3 (es) Compuestos terapeuticos.
NO923642L (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
NO923546L (no) Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde
HU9301364D0 (en) Homo-prostaglandines applicables for treatment of hypertension in eyes
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
IT1226796B (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee